Previous Page  34 / 38 Next Page
Information
Show Menu
Previous Page 34 / 38 Next Page
Page Background

PROSPER/SPARTAN

: secondary end-point OS

Smith MR, et al. NEJM 2018; Hussain M, et al. NEJM 2018